TNM staging management system of respiratory system
By adding the TMN staging prediction management unit and abnormal lymph node recognition unit to the respiratory system TNM staging management system, the shortcomings of the existing system in lymph node staging management are solved, and accurate prediction of primary tumors, lymphatic metastasis and distant metastasis are achieved. and diagnosis improves the scientificity and accuracy of the treatment plan.
Patent Information
- Application Number
- CN202411131087.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-29
AI Technical Summary
The existing respiratory TNM staging management system is not perfect in lymph node staging management, making it difficult to conduct comprehensive diagnosis and information identification, resulting in difficulties in accurately judging the patient's tumor situation and formulating treatment plans.
A TNM staging management system for the respiratory system was designed, including a panoramic scanning module for chest CT images under enhanced conditions, TMN staging prediction management unit, lymph node collection unit, tumor primary foci calculation unit, lymph node model entry unit, and area box selection identification Units, lymph node recording units, lymph node metastasis determination units and abnormal lymph node identification units, through the interconnection and functional combination of these modules, the prediction and diagnosis of primary tumors, lymph node metastasis and distant metastasis are achieved.
The accuracy of TNM staging management is improved, and through the identification and status verification of lymph nodes, the accurate identification of lymph node abnormalities is achieved, and the ability to determine lymph node metastasis and guide the treatment plan is enhanced.
Smart Images

Figure CN119048360A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of TNM staging management, and in particular to a TNM staging management system for the respiratory system. Background Art
[0002] The International TNM staging system is an internationally recognized clinical staging method developed by the "International Anti-Cancer Association". It is not only of great guiding significance for the treatment of breast cancer, but also for determining the prognosis of cancer. The International TNM staging system does not identify the pathological tissue type of the tumor, but only makes an objective judgment on the severity and scope of the tumor. The International TNM staging system first divides the clinical situation of the cancer into three aspects: primary tumor: the initial letter "T" of Tumor, lymph node metastasis: the initial letter "N" of Node, and distant metastasis: the initial letter "M" of Metastasis. Under each letter, numbers such as 0, 1, 2, and 3 are added to indicate the severity and scope of cancer cell invasion in each aspect, so as to clearly indicate the primary focus, lymph node metastasis and other distant metastasis of malignant cancer. According to the TNM staging, people can clearly summarize the clinical stage of cancer patients, judge the prognosis, and guide doctors to develop the best treatment plan for patients. In the existing respiratory department, lung tumors need to be managed by TMN staging. However, the existing TMN staging management system often focuses on T, that is, the primary tumor, and is not perfect in the staging management of lymph nodes. It is not convenient to identify and process the information of the patient's existing lymph nodes and conduct a comprehensive diagnosis and treatment of the patient's tumor condition. Summary of the invention
[0003] The purpose of the present invention is to provide a TNM staging management system for the respiratory system to solve the problems raised in the above background technology.
[0004] To achieve the above-mentioned purpose, the present invention provides the following technical solutions: a TNM staging management system for a respiratory system, comprising a chest CT image panoramic scanning module under enhanced conditions, a TMN staging prediction management unit, a lymph node acquisition unit, a tumor primary focus calculation unit, a lymph node model entry unit, a regional frame selection and identification unit, a lymph node recording unit, a lymph node metastasis determination unit and an abnormal lymph node identification unit, wherein the output end of the chest CT image panoramic scanning module under enhanced conditions is communicatively connected to the input end of the TMN staging prediction management unit, the TMN staging prediction management unit is bidirectionally connected to the lymph node acquisition unit, the lymph node acquisition unit is bidirectionally connected to the tumor primary focus calculation unit, the lymph node acquisition unit is bidirectionally connected to the lymph node model entry unit, the output end of the lymph node acquisition unit is communicatively connected to the input end of the regional frame selection and identification unit, the output end of the regional frame selection and identification unit is communicatively connected to the input end of the lymph node recording unit, the output end of the lymph node recording unit is communicatively connected to the input end of the lymph node metastasis determination unit, and the lymph node metastasis determination unit is bidirectionally connected to the abnormal lymph node identification unit;
[0005] The chest CT image panoramic scanning module under enhanced conditions is used to perform panoramic scanning acquisition processing on the chest CT images under enhanced conditions of the left lung and the right lung;
[0006] The TMN staging prediction management unit is used to predict and process primary tumors, lymph node metastases, and distant metastatic tumors;
[0007] The lymph node acquisition unit is used to identify the location of the lymph nodes in the image;
[0008] The tumor primary focus calculation unit is used to perform information identification processing on the primary tumor;
[0009] The lymph node model input unit is used to extract the features of the lymph nodes and input the lymph node model;
[0010] The region frame selection and identification unit is used to perform frame selection and recording processing on the information of the lymph node region;
[0011] The lymph node recording unit is used to manage the number and status of lymph nodes in stages;
[0012] The lymph node metastasis determination unit is used to determine whether there is lymph node metastasis;
[0013] The abnormal lymph node identification unit is used to identify and process the status information of the abnormal lymph nodes.
[0014] Preferably, the TMN staging prediction management unit includes a T staging prediction module, an M staging prediction module and an N staging prediction module;
[0015] The T staging prediction module is used to summarize clinical staging according to the primary tumor status and guide the best treatment plan;
[0016] The M staging prediction module is used to summarize clinical staging and guide the best treatment plan according to the status of lymph node metastasis;
[0017] The N staging prediction module is used to summarize clinical staging according to the status of distant tumor metastasis and guide the best treatment plan.
[0018] Preferably, the lymph node collection unit comprises a lymph node identification module and a lymph node location acquisition module, and the output end of the lymph node identification module is communicatively connected to the input end of the lymph node location acquisition module;
[0019] The lymph node recognition module is used to recognize and process the appearance of lymph nodes in the chest CT image under enhanced conditions based on the image of the lymph node model input unit;
[0020] The lymph node location acquisition module is used to identify the location of each lymph node in the body.
[0021] Preferably, the tumor primary focus calculation unit comprises a tumor size measurement module and a tumor malignancy judgment module, and the tumor size measurement module is bidirectionally connected with the tumor malignancy judgment module;
[0022] The tumor size measurement module is used to measure the diameter and volume of the existing tumor;
[0023] The tumor malignancy judgment module is used to judge the malignancy or benignity of a tumor.
[0024] Preferably, the region selection and identification unit comprises a lymph node region image extraction module and a lymph node model comparison and confirmation module, and the output end of the lymph node region image extraction module is communicatively connected to the input end of the lymph node model comparison and confirmation module;
[0025] The lymph node region image extraction module is used to extract and process the region image within the identified lymph node;
[0026] The lymph node model comparison and confirmation module is used to perform regional image comparison processing with the lymph node model and perform comparison and identification processing on the status of the lymph nodes.
[0027] Preferably, the lymph node recording unit comprises a lymph node metastasis number recording module and a lymph node staging data module, and the output end of the lymph node metastasis number recording module is communicatively connected to the input end of the lymph node staging data module;
[0028] The lymph node metastasis number recording module is used to calculate the number of lymph nodes with metastasis;
[0029] The lymph node staging data module is used to obtain staging data of the treated lymph nodes.
[0030] Preferably, the abnormal lymph node identification unit comprises a lymph node image extraction module, a color inversion module and a color enhancement module, the output end of the lymph node image extraction module is communicatively connected to the input end of the color inversion module, and the color inversion module is bidirectionally connected to the color enhancement module;
[0031] The lymph node image extraction module is used to extract and process the image of the lymph node position;
[0032] The color inversion module is used to perform color inversion observation processing on the extracted lymph node image;
[0033] The color enhancement module is used to perform color enhancement on the image of the lymph node position.
[0034] Preferably, the lymph node collection unit is bidirectionally connected to a distant tissue metastasis identification unit, and the distant tissue metastasis identification unit is used to identify and process the presence of distant metastasis of the tumor. The area selection identification unit is bidirectionally connected to a digital additional module, and the digital additional module is used to perform equidistant differentiation processing by digital means according to the condition of the disease.
[0035] Preferably, the lymph node recording unit is bidirectionally connected to a region information display unit, and the region information display unit is used to independently display information data of each lymph node region.
[0036] Preferably, the abnormal lymph node identification unit is bidirectionally connected to a transfer probability calculation unit, and the transfer probability calculation unit is used to analyze and calculate the probability of lymph node metastasis based on the lymph node image.
[0037] It is to be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present disclosure.
[0038] Compared with the prior art, the beneficial effects of the present invention are as follows: by adding a TMN staging prediction management unit, the conditions of the primary tumor, lymph node metastasis and distant metastasis can be predicted, and the subsequent treatment can be managed according to the predicted conditions; by adding a regional frame selection recognition unit, it is used to perform status verification processing on the lymph nodes through the lymph node model, and to identify the existence of lymph nodes and abnormal conditions of the image; by adding an abnormal lymph node recognition unit, the image color of the lymph node image can be changed and enhanced, thereby accurately identifying the abnormal conditions of the lymph nodes and improving the accuracy of TNM staging management. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] In order to more clearly illustrate the implementation methods of the present invention or the technical solutions in the prior art, the drawings required for the implementation methods or the prior art descriptions are briefly introduced below. Obviously, the drawings in the following description are only exemplary, and for ordinary technicians in this field, other implementation drawings can be derived from the provided drawings without creative work.
[0040] Figure 1 is a system block diagram of the present invention;
[0041] Figure 2 This is a system block diagram of the TMN phase prediction management unit of the present invention;
[0042] Figure 3 This is a system block diagram of the primary tumor focus calculation unit of the present invention;
[0043] Figure 4 This is a system block diagram of the abnormal lymph node identification unit of the present invention. DETAILED DESCRIPTION
[0044] Exemplary embodiments will be described in detail herein, examples of which are shown in the accompanying drawings. When the following description refers to the drawings, the same numbers in different drawings represent the same or similar elements unless otherwise indicated. The embodiments described in the following exemplary embodiments do not represent all embodiments consistent with the present disclosure. Instead, they are merely examples of devices consistent with some aspects of the present disclosure as detailed in the appended claims.
[0045] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the accompanying drawings in the embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0046] Embodiment 1:
[0047] See also Figures 1 to 4As shown, the TNM staging management system for the respiratory system of the embodiment of the present invention includes a chest CT image panoramic scanning module under enhanced conditions, a TMN staging prediction management unit, a lymph node acquisition unit, a tumor primary focus calculation unit, a lymph node model entry unit, a regional frame selection and identification unit, a lymph node recording unit, a lymph node metastasis determination unit and an abnormal lymph node identification unit, the output end of the chest CT image panoramic scanning module under enhanced conditions is communicatively connected to the input end of the TMN staging prediction management unit, the TMN staging prediction management unit is bidirectionally connected to the lymph node acquisition unit, the lymph node acquisition unit is bidirectionally connected to the tumor primary focus calculation unit, the lymph node acquisition unit is bidirectionally connected to the lymph node model entry unit, the output end of the lymph node acquisition unit is communicatively connected to the input end of the regional frame selection and identification unit, the output end of the regional frame selection and identification unit is communicatively connected to the input end of the lymph node recording unit, the output end of the lymph node recording unit is communicatively connected to the input end of the lymph node metastasis determination unit, and the lymph node metastasis determination unit is bidirectionally connected to the abnormal lymph node identification unit;
[0048] The chest CT image panoramic scanning module under enhanced conditions is used to perform panoramic scanning acquisition processing on the chest CT images under enhanced conditions of the left lung and the right lung, and perform panoramic scanning processing on the images acquired from the left lung and the right lung of the patient;
[0049] The TMN staging prediction management unit is used to predict the primary tumor, lymph node metastasis and distant metastasis. The addition of the TMN staging prediction management unit enables the prediction of the primary tumor, lymph node metastasis and distant metastasis, and manages the subsequent treatment according to the predicted situation;
[0050] The lymph node acquisition unit is used to identify the location of lymph nodes in the image, identify the lymph nodes in the patient according to the lymph node model, and mark the location of the lymph nodes;
[0051] The primary tumor lesion calculation unit is used to perform information recognition and processing on the primary tumor;
[0052] The lymph node model input unit is used to extract the features of the lymph nodes and input the lymph node model;
[0053] The regional frame selection and recognition unit is used to frame and record the information of the lymph node area. The regional frame selection and recognition unit is added to check the status of the lymph nodes through the lymph node model, identify the existence of the lymph nodes and the abnormal conditions of the image, extract the image of the area where the lymph nodes exist, and identify and compare the image size of the lymph nodes;
[0054] The lymph node recording unit is used to manage the number and status of lymph nodes in stages and to record the number of lymph node metastases;
[0055] The lymph node metastasis determination unit is used to determine whether there is lymph node metastasis;
[0056] The abnormal lymph node recognition unit is used to identify and process the status information of abnormal lymph nodes. The addition of the abnormal lymph node recognition unit realizes the change and enhancement of the image color of the lymph node image, thereby accurately identifying the abnormal condition of the lymph nodes, improving the accuracy of TNM staging management, extracting the image of the abnormal lymph nodes, and inverting and enhancing the image color, fully identifying the abnormal lymph nodes, and performing stable calculation processing on the TNM staging management.
[0057] Embodiment 2:
[0058] Among them, the TMN staging prediction management unit includes a T staging prediction module, an M staging prediction module and an N staging prediction module;
[0059] The T staging prediction module is used to summarize clinical staging based on the status of the primary tumor and guide the best treatment plan;
[0060] The M staging prediction module is used to summarize clinical staging and guide the best treatment plan based on the status of lymph node metastasis;
[0061] The N staging prediction module is used to summarize clinical staging and guide the best treatment plan based on the status of distant tumor metastasis. The TMN staging prediction management unit has been added to predict the status of primary tumors, lymph node metastasis and distant metastasis, and manage subsequent treatment based on the predicted status.
[0062] The lymph node collection unit includes a lymph node identification module and a lymph node location acquisition module, and the output end of the lymph node identification module is communicatively connected with the input end of the lymph node location acquisition module;
[0063] The lymph node recognition module is used to recognize and process the appearance of the lymph nodes in the chest CT image under enhanced conditions based on the image of the lymph node model input unit;
[0064] The lymph node location acquisition module is used to identify the location of each lymph node in the body, identify the lymph nodes in the patient based on the lymph node model, and mark and acquire the location of the lymph nodes.
[0065] The primary tumor focus calculation unit includes a tumor size measurement module and a tumor malignancy judgment module, and the tumor size measurement module is bidirectionally connected with the tumor malignancy judgment module;
[0066] The tumor size measurement module is used to measure the diameter and volume of the existing tumor;
[0067] The tumor malignancy judgment module is used to judge the malignancy and benignity of the tumor.
[0068] The region selection and identification unit includes a lymph node region image extraction module and a lymph node model comparison and confirmation module, and the output end of the lymph node region image extraction module is communicatively connected with the input end of the lymph node model comparison and confirmation module;
[0069] The lymph node region image extraction module is used to extract and process the region image within the identified lymph node;
[0070] The lymph node model comparison and confirmation module is used to perform regional image comparison processing with the lymph node model and to compare and identify the status of the lymph nodes. A regional frame selection and recognition unit is added to verify the status of the lymph nodes through the lymph node model, identify the existence of lymph nodes and abnormal conditions of the image, extract images of the area where the lymph nodes are located, and identify and compare the image size of the lymph nodes.
[0071] The lymph node recording unit includes a lymph node metastasis number recording module and a lymph node staging data module, and the output end of the lymph node metastasis number recording module is communicatively connected with the input end of the lymph node staging data module;
[0072] The lymph node metastasis number recording module is used to calculate and process the number of lymph node metastasis conditions;
[0073] The lymph node staging data module is used to obtain the staging data of the treated lymph nodes.
[0074] The abnormal lymph node identification unit includes a lymph node image extraction module, a color inversion module and a color enhancement module. The output end of the lymph node image extraction module is communicatively connected to the input end of the color inversion module, and the color inversion module is bidirectionally connected to the color enhancement module.
[0075] The lymph node image extraction module is used to extract and process the image of the lymph node position;
[0076] The color inversion module is used to perform color inversion observation processing on the extracted lymph node images;
[0077] The color enhancement module is used to enhance the color of the image of the lymph node location. An abnormal lymph node identification unit is added to change and enhance the image color of the lymph node image, thereby accurately identifying the abnormal condition of the lymph nodes, improving the accuracy of TNM staging management, extracting the image of the abnormal lymph nodes, and inverting and enhancing the color of the image, fully identifying the abnormal lymph nodes, and performing stable calculation processing for TNM staging management.
[0078] Among them, the lymph node collection unit is bidirectionally connected to the distant tissue metastasis identification unit, and the distant tissue metastasis identification unit is used to identify and process the existence of distant metastasis of the tumor. The area selection identification unit is bidirectionally connected to the digital additional module, and the digital additional module is used to perform equidistant differentiation processing through numbers according to the condition of the disease, mark the lymph node problems according to the digital additional module, and digitally mark the lymph node according to the condition of the lymph node.
[0079] The lymph node recording unit is bidirectionally connected to the regional information display unit, and the regional information display unit is used to independently display and process the information data of each lymph node region.
[0080] The abnormal lymph node identification unit is bidirectionally connected to a transfer probability calculation unit, and the transfer probability calculation unit is used to analyze and calculate the probability of lymph node metastasis based on the lymph node image.
[0081] Embodiment 3:
[0082] The images obtained from the patient's left and right lungs are scanned panoramically, and the primary tumor, lymph node metastasis and distant metastasis are predicted. The lymph nodes in the patient are identified based on the lymph node model, and the locations of the lymph nodes are marked and acquired. The images of the areas where the lymph nodes are located are extracted separately, and the image sizes of the lymph nodes are identified and compared. The problems with the lymph nodes are identified and marked according to the digital additional module. The lymph nodes are digitally marked according to their conditions. At the same time, the number of lymph node metastases is recorded, and the disease information of the lymph nodes in the region is recorded and displayed. The status of lymph node metastasis is judged and processed, the images of abnormal lymph nodes are extracted, and the image colors are inverted and enhanced. The abnormal lymph nodes are fully identified, and the TNM staging management is stably calculated.
[0083] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
[0084] Those skilled in the art will readily appreciate other embodiments of the present disclosure after considering the specification and practicing the disclosure disclosed herein. This application is intended to cover any variations, uses, or adaptations of the present disclosure that follow the general principles of the present disclosure and include common knowledge or customary techniques in the art that are not disclosed in the present disclosure. The description and examples are intended to be exemplary only, and the true scope of the present disclosure is indicated by the following claims.
Claims
1. The TNM staging management system for the respiratory system is characterized by: It includes a chest CT image panoramic scanning module under enhanced conditions, a TMN staging prediction management unit, a lymph node acquisition unit, a tumor primary focus calculation unit, a lymph node model entry unit, a regional frame selection and identification unit, a lymph node recording unit, a lymph node metastasis determination unit and an abnormal lymph node identification unit, wherein the output end of the chest CT image panoramic scanning module under enhanced conditions is communicatively connected to the input end of the TMN staging prediction management unit, the TMN staging prediction management unit is bidirectionally connected to the lymph node acquisition unit, the lymph node acquisition unit is bidirectionally connected to the tumor primary focus calculation unit, the lymph node acquisition unit is bidirectionally connected to the lymph node model entry unit, the output end of the lymph node acquisition unit is communicatively connected to the input end of the regional frame selection and identification unit, the output end of the regional frame selection and identification unit is communicatively connected to the input end of the lymph node recording unit, the output end of the lymph node recording unit is communicatively connected to the input end of the lymph node metastasis determination unit, and the lymph node metastasis determination unit is bidirectionally connected to the abnormal lymph node identification unit; The chest CT image panoramic scanning module under enhanced conditions is used to perform panoramic scanning acquisition processing on the chest CT images under enhanced conditions of the left lung and the right lung; The TMN staging prediction management unit is used to predict and process primary tumors, lymph node metastases, and distant metastatic tumors; The lymph node acquisition unit is used to identify the location of the lymph nodes in the image; The tumor primary focus calculation unit is used to perform information identification processing on the primary tumor; The lymph node model input unit is used to extract the features of the lymph nodes and input the lymph node model; The region frame selection and identification unit is used to perform frame selection and recording processing on the information of the lymph node region; The lymph node recording unit is used to manage the number and status of lymph nodes in stages; The lymph node metastasis determination unit is used to determine whether there is lymph node metastasis; The abnormal lymph node identification unit is used to identify and process the status information of the abnormal lymph nodes.
2. The TNM staging management system for the respiratory system according to claim 1, characterized in that: The TMN staging prediction management unit includes a T staging prediction module, an M staging prediction module and an N staging prediction module; The T staging prediction module is used to summarize clinical staging according to the primary tumor status and guide the best treatment plan; The M staging prediction module is used to summarize clinical staging and guide the best treatment plan according to the status of lymph node metastasis; The N staging prediction module is used to summarize clinical staging according to the status of distant tumor metastasis and guide the best treatment plan.
3. The TNM staging management system for the respiratory system according to claim 2, characterized in that: The lymph node collection unit includes a lymph node identification module and a lymph node location acquisition module, and the output end of the lymph node identification module is communicatively connected to the input end of the lymph node location acquisition module; The lymph node recognition module is used to recognize and process the appearance of lymph nodes in the chest CT image under enhanced conditions based on the image of the lymph node model input unit; The lymph node location acquisition module is used to identify the location of each lymph node in the body.
4. The TNM staging management system for the respiratory system according to claim 3, characterized in that: The tumor primary focus calculation unit includes a tumor size measurement module and a tumor malignancy judgment module, and the tumor size measurement module is bidirectionally connected with the tumor malignancy judgment module; The tumor size measurement module is used to measure the diameter and volume of the existing tumor; The tumor malignancy judgment module is used to judge the malignancy or benignity of a tumor.
5. The TNM staging management system for the respiratory system according to claim 4, characterized in that: The area selection and identification unit includes a lymph node area image extraction module and a lymph node model comparison and confirmation module, and the output end of the lymph node area image extraction module is communicatively connected to the input end of the lymph node model comparison and confirmation module; The lymph node region image extraction module is used to extract and process the region image within the identified lymph node; The lymph node model comparison and confirmation module is used to perform regional image comparison processing with the lymph node model and perform comparison and identification processing on the status of the lymph nodes.
6. The TNM staging management system for the respiratory system according to claim 5, characterized in that: The lymph node recording unit includes a lymph node metastasis number recording module and a lymph node staging data module, and the output end of the lymph node metastasis number recording module is communicatively connected with the input end of the lymph node staging data module; The lymph node metastasis number recording module is used to calculate the number of lymph nodes with metastasis; The lymph node staging data module is used to obtain staging data of the treated lymph nodes.
7. The TNM staging management system for the respiratory system according to claim 6, characterized in that: The abnormal lymph node identification unit includes a lymph node image extraction module, a color inversion module and a color enhancement module, wherein the output end of the lymph node image extraction module is communicatively connected to the input end of the color inversion module, and the color inversion module is bidirectionally connected to the color enhancement module; The lymph node image extraction module is used to extract and process the image of the lymph node position; The color inversion module is used to perform color inversion observation processing on the extracted lymph node image; The color enhancement module is used to perform color enhancement on the image of the lymph node position.
8. The TNM staging management system for the respiratory system according to claim 7, characterized in that: The lymph node collection unit is bidirectionally connected to a distant tissue metastasis identification unit, and the distant tissue metastasis identification unit is used to identify and process the presence of distant metastasis of the tumor. The area selection identification unit is bidirectionally connected to a digital additional module, and the digital additional module is used to perform equidistant differentiation processing through numbers according to the condition of the disease.
9. The TNM staging management system for the respiratory system according to claim 8, characterized in that: The lymph node recording unit is bidirectionally connected to a region information display unit, and the region information display unit is used to independently display the information data of each lymph node region.
10. The TNM staging management system for the respiratory system according to claim 9, characterized in that: The abnormal lymph node identification unit is bidirectionally connected to a transfer probability calculation unit, and the transfer probability calculation unit is used to analyze and calculate the probability of lymph node metastasis based on the lymph node image.
Citation Information
Cited By
Large-model intelligent TNM staging system construction method based on pathological report and TNM standard
CN119964715A
